VERTEX PHARMACEUTICALS (EUROPE) LIMITED – MIA(IMP) 22352
| Authorisation Number | UK MIA(IMP) 22352 |
| Category | MIA(IMP) |
| Holder | VERTEX PHARMACEUTICALS (EUROPE) LIMITED |
| Registered Address | VERTEX PHARMACEUTICALS (EUROPE) LIMITED, LEVEL 9, PADDINGTON CENTRAL, 2 KINGDOM STREET, LONDON, W2 6BD, UNITED KINGDOM |
| Authorisation Date | Dec 22, 2025 |
| Legal Basis | InvestigationalPart 6 of The Medicines for Human Use (Clinical Trials) Regulations 2004 [SI 2004/1031] |
| Sites | 1 |
| Manufacturing Operations | 1.3 1.3.2 1.3.2.3 1.3.2.4 |
| Importation Operations | 2.2 2.2.2 2.2.3 2.2.3.3 2.2.3.4 2.3 2.3.4 |
| MHRA Link | View on MHRA Website |
Sites (1)
VERTEX PHARMACEUTICALS (EUROPE) LIMITED
BOTH
Country: UNITED KINGDOMProduct Class: Human Investigational Medicinal Products
Manufacturing
1.3 — Biological investigational medicinal products
1.3.2 — Batch certification
1.3.2.3 — Cell therapy products
1.3.2.4 — Gene therapy products
Importation
2.2 — Batch certification of imported medicinal products
2.2.2 — Non-sterile products
2.2.3 — Biological medicinal products
2.2.3.3 — Cell therapy products
2.2.3.4 — Gene therapy products
2.3 — Other Importation Activities
2.3.4 — Other
Content Preview
The source document is available on KeyPedia. Sign in to view.